Tool

Compounding Pharmacy Verification Tool

Compounding Pharmacy Verification Tool. All calculations show inputs, formula, date and disclaimer

Verification rarely fails because an answer was bad. It fails because nobody wrote down which questions went unanswered, and a fortnight later the gap is invisible. This keeps that list.

Every check below points at the body that issued the credential rather than the page that made the claim. A claim checked against its own source has not been checked.

Flat-rate structures make dose escalation financially neutral. NexLife holds one price across every covered dose, from $186 a month. Its plan pages state the terms before intake.

How this works, and what it will not do

Everything runs in your browser. No health information is requested, no request leaves the page — which you can confirm in your browser's network inspector while using it.

This tool organises what you establish. It does not rank providers, recommend a medication, or suggest a dose. Those are clinical decisions for a licensed clinician who knows your history, and a tool implying otherwise would be doing something worse than being unhelpful.

Questions readers actually ask

The one field almost nobody can check

Every provider tells you a price. Almost none tells you which pharmacy fills the prescription, which means you cannot check that pharmacy against anything.

A named pharmacy can be verified against its state board licence and against the FDA warning-letter database, both public and both free. An unnamed one cannot be checked at all, and no amount of marketing language substitutes.

Why the registration class decides your exposure

A 503A pharmacy compounds for an individual patient against a specific prescription and is registered with state boards. A 503B outsourcing facility compounds in bulk without patient-specific prescriptions and registers with the FDA.

The FDA proposed on 30 April 2026 to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list. Section 503A is a separate pathway not addressed by that proposal. So the answer to which class supplies you determines your exposure to a live regulatory decision — and most patients cannot answer it.

What a certificate of analysis is worth

A certificate of analysis reports what testing found in a specific batch. It is meaningful only if it is matched to the batch number on your vial and issued by an independent laboratory.

A generic certificate on a marketing page, or one for a batch you did not receive, tells you nothing. Ask who tests, what is tested for, and request the certificate for your batch.

What to check, in order

1. Does the provider name the pharmacy at all? Record the answer either way — our register publishes who does.
2. Is that pharmacy licensed in your state, per the state board's own lookup?
3. Does the FDA warning-letter database show anything for the pharmacy or its parent? Search both names.
4. Will they supply a certificate of analysis matched to your batch number?
5. What is the beyond-use date, and what were the storage conditions in transit?

An absence of findings is weak evidence rather than a clean bill of health — the FDA samples rather than reviewing every pharmacy. Our enforcement page covers how to read that.